Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells
2011 (English)In: Blood Cancer Journal, ISSN 2044-5385, Vol. 1, no e31, 9- p.Article in journal (Refereed) Published
Malignant cells are known to have increased glucose uptake and accelerated glucose metabolism. Using liquid chromatography and mass spectrometry, we found that treatment of acute lymphoblastic leukemia (ALL) cells with the glucocorticoid (GC) dexamethasone (Dex) resulted in profound inhibition of glycolysis. We thus demonstrate that Dex reduced glucose consumption, glucose utilization and glucose uptake by leukemic cells. Furthermore, Dex treatment decreased the levels of the plasma membrane-associated glucose transporter GLUT1, thus revealing the mechanism for the inhibition of glucose uptake. Inhibition of glucose uptake correlated with induction of cell death in ALL cell lines and in leukemic blasts from ALL patients cultured ex vivo. Addition of di-methyl succinate could partially overcome cell death induced by Dex in RS4;11 cells, thereby further supporting the notion that inhibition of glycolysis contributes to the induction of apoptosis. Finally, Dex killed RS4;11 cells significantly more efficiently when cultured in lower glucose concentrations suggesting that modulation of glucose levels might influence the effectiveness of GC treatment in ALL. In summary, our data show that GC treatment blocks glucose uptake by leukemic cells leading to inhibition of glycolysis and that these effects play an important role in the induction of cell death by these drugs.
Place, publisher, year, edition, pages
Macmillan Publishers Limited , 2011. Vol. 1, no e31, 9- p.
glucocorticoids, leukemia, glycolysis, cell death
IdentifiersURN: urn:nbn:se:umu:diva-48269DOI: 10.1038/bcj.2011.27OAI: oai:DiVA.org:umu-48269DiVA: diva2:448443